Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

The Wuhan company didn’t bother with the dark web. It spruiked its goods right in the open, showing mounds of white powder ...

She started on Nickelodeon, before becoming a global pop sensation. Now, Grande is back in Hollywood, and the 'Wicked' star ...

Nearly 22,000 pounds of fentanyl were seized at US borders during the 2024 fiscal year, according to data from the US Customs ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

President Trump’s tariffs in China are in place and hitting all products imported from the country — including a number of pharmaceutical drugs that Americans rely upon. Chinese imports ...

The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

Learn about various drugs, from their dosages and potential side effects to pricing and administration guidelines, to find the right solution for managing Stress Incontinence symptom effectively.